Conclusion The intersection of GLP-1 weight loss medications and life insurance underwriting is creating new challenges for agents and clients alike
Both contain the same active ingredient and produce similar weight loss results
Originally designed to help people with type 2 diabetes manage blood sugar, its now widely used for weight loss too
And although GLP-1 drugs have an overall favorable benefit-risk profile when appropriately prescribed, they are not benign: Gastrointestinal effects are common, discontinuation is frequent in real-world settings, and regulators continue to monitor rarer concerns including gallbladder disease, pancreatitis, aspiration risk, and psychiatric symptoms
But heres what nearly everyone discovers after the first couple of rounds: Its quicker, easier, and far less painful than you imagined
Whether acquired through commercial sources or compounded formulations, these results validate its role as a very effective treatment option